
We value conversations with our customers. Therefore you can always send us a private message: x.com/messages/compose?recip…

Official X handle of Intervet Inc. DBA Merck Animal Health. Intended for U.S. residents only. The Science of Healthier Animals®. merck.com/privacy

We value conversations with our customers. Therefore you can always send us a private message: x.com/messages/compose?recip…

Today we announced that the European Commission has granted marketing authorization for a new vaccine to reduce viraemia and clinical signs of disease caused by avian reovirus (ARV) genotypes 1 and 4. Learn more: lnkd.in/ePUUVTtD

Today, we announced that S&P Global Animal Health awarded our year-long flea & tick solution the Best New Companion Animal product. We remain committed to providing customers with innovative solutions that shape the future of animal health. Read more: bit.ly/41671oO

Today, we received EU approval for our canine chewable tablet, designed for one month of treatment against internal and external parasites. Click below to learn more.


Today we announce the FDA approval of the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens and for the treatment and control of adult Ascaridia galli and Heterakis gallinarium in breeding chickens and laying hens. bit.ly/48Mhtns

Today we announced the European Medicines Agency approval for expanded Indication for our coronavirus and rotavirus vaccine for cattle. This approval allows our vaccine to be administered intramuscularly or through subcutaneous injection. Read more: bit.ly/4067siV

We’re proud to announce the EU approval of our latest swine solution; a ready-to-use intradermal vaccine that offers protection against two of the most common swine pathogens. Learn more: bit.ly/3BhtTal

We’re proud to announce the USDA approval of the latest addition to our feline solutions portfolio; a new vaccine designed to protect cats against feline leukemia virus (FeLV).


Today, we announced the completion of the acquisition of Elanco's aqua business, consisting of an innovative portfolio of medicines and vaccines, nutritionals and supplements. Read more: bit.ly/3Lh68kp

We’re proud to announce our USDA approval for a next-level vaccine solution to protect dogs against canine influenza, leveraging RNA-particle technology.


Today, we received EU approval for our avian influenza vaccine. Any use of vaccines for HPAI should be done in conjunction with rigorous biosecurity and surveillance programs and in line with Government regulations. Click below to learn more.


We are excited to provide an update on our latest poultry innovation for laying and breeding chickens. Learn more: bit.ly/PoultrySolutions

Introducing Sensehub® Dairy Youngstock – the industry's first monitoring technology that provides producers with real-time data on the behavior & well-being of dairy calves from birth through the first 12 months of life.


We are excited to provide an update on our poultry innovation for laying and breeding chickens against the most important viral pathogens. This milestone brings us closer to achieving the first 9-valent inactivated viral vaccine in Europe. shorturl.at/bhoFQ

Thank you for joining us at this year’s #IPPE2024. We were proud to showcase our support for the next generation of talent and demonstrate our advancements in the poultry industry. #WhyWeInnovate

Remaining focused on development, Chus Pérez transitioned to a general manager role to better support our customers. As our company develops new solutions, she remains focused on critical tasks to ensure our customers are at the forefront. #IAmAnimalHealth